Judge: Investors Failed To Plead Falsity In Stock-Drop Case Against Drug Maker

(November 9, 2016, 5:24 PM EST) -- SAN FRANCISCO — Shareholders in a securities class action lawsuit against a clinical-stage biopharmaceutical company and others failed to plead falsity in making their federal securities law claims, a federal judge...

To view the full article, register now.